Memorial Sloan Kettering radiation oncologist Daniel Gomez

Daniel Gomez, MD, MBA

Radiation Oncologist


Director of Thoracic Oncology; Chief of Radiation Oncology, Manhattan Service

Clinical Expertise

Lung Cancer; Metastases; Mesothelioma/Thymoma; Esophageal Cancer

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Gomez accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me


MD, University of California San Francisco (2004), MBA, Rice University


Radiation Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

Radiation Oncology

Ever since I was five years old, I wanted to become a doctor. While doing cancer research during medical school, I was drawn to radiation oncology. Today, I am a radiation oncologist who cares for people with thoracic cancer, such as lung cancer, mesothelioma, thymoma, and esophageal cancer. I completed my residency training at Memorial Sloan Kettering Cancer Center and then moved to Houston, where I worked at MD Anderson Cancer Center for almost ten years.

I am currently a member of the Disease Management Teams caring for people with thoracic cancer and people with cancer that has spread to another area of the body, which is also called metastatic disease. I continue to do research in both of these areas. My research focuses on using radiation therapy to treat stage IV disease. I have led and collaborated on multiple studies examining the role of radiation therapy for stage IV cancer. In particular, my colleagues and I have selected people with stage IV disease who may benefit from more aggressive treatment.

Research is important in identifying the best treatment for a patient, but I gain the most fulfillment from being involved in my patients’ challenging cancer journeys. That is the most rewarding component of my work. I always do my best to convey to patients that their care is my highest priority, and that I am honored to share this part of their lives with them and their loved ones.

Research is important in identifying the best treatment for a patient, but I gain the most fulfillment from being involved in my patients’ challenging cancer journeys.

Dr. Gomez

Awards and Honors

  • Steven A. Leibel Memorial Award for Research, American Society of Radiation Oncology/American Board of Radiology (2018)
  • James D. Cox Mentoring Award (2017)


Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Gomez D (corresponding author), Blumenschein GR, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, Sepesi B, William WN, Zhang J, Shi Q, Wang XS, Swisher SG, Heymach JV (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncology 17(12):1672-1682. 

Gomez D, Yusuf SW, Munsell MF, Welsh JW, Liao Z, Lin SH, Pan HY, Chang JY, Komaki R, Cox JD, McAleer MF, Grosshans DR (2014) Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure. Journal of Thoracic Oncology 9(10):1554-60.

Gomez D, Hong DS, Allen PK, Welsh JS, Mehran RJ, Tsao AS, Liao Z, Bilton SD, Komaki R, Rice DC (2013) Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. Journal of Thoracic Oncology 8(2):238-45.

Gomez D, Cox JD, Roth JA, Allen PK, Wei X, Mehran RJ, Kim JY, Swisher SG, Rice DC, Komaki R (2012) A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors. Cancer 118(2):444-451.